- Home
- XENE vs NEA Comparison
XENE vs NEA Comparison
Compare XENE & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- NEA
- Stock Information
- Founded
- XENE 1996
- NEA 2002
- Country
- XENE Canada
- NEA United States
- Employees
- XENE N/A
- NEA N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- NEA Finance/Investors Services
- Sector
- XENE Health Care
- NEA Finance
- Exchange
- XENE Nasdaq
- NEA Nasdaq
- Market Cap
- XENE 3.3B
- NEA 3.5B
- IPO Year
- XENE 2014
- NEA N/A
- Fundamental
- Price
- XENE $41.08
- NEA $11.46
- Analyst Decision
- XENE Strong Buy
- NEA
- Analyst Count
- XENE 9
- NEA 0
- Target Price
- XENE $56.67
- NEA N/A
- AVG Volume (30 Days)
- XENE 361.3K
- NEA 803.4K
- Earning Date
- XENE 11-12-2024
- NEA 01-01-0001
- Dividend Yield
- XENE N/A
- NEA 4.23%
- EPS Growth
- XENE N/A
- NEA N/A
- EPS
- XENE N/A
- NEA N/A
- Revenue
- XENE N/A
- NEA N/A
- Revenue This Year
- XENE N/A
- NEA N/A
- Revenue Next Year
- XENE $1,599.99
- NEA N/A
- P/E Ratio
- XENE N/A
- NEA N/A
- Revenue Growth
- XENE N/A
- NEA N/A
- 52 Week Low
- XENE $35.53
- NEA $9.20
- 52 Week High
- XENE $50.99
- NEA $11.37
- Technical
- Relative Strength Index (RSI)
- XENE 48.67
- NEA 35.37
- Support Level
- XENE $38.95
- NEA $11.84
- Resistance Level
- XENE $43.20
- NEA $11.92
- Average True Range (ATR)
- XENE 1.51
- NEA 0.09
- MACD
- XENE -0.11
- NEA -0.04
- Stochastic Oscillator
- XENE 51.27
- NEA 3.19
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities.